{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:52:04Z","timestamp":1793332324534,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031336","name":"Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110648","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:24:25Z","timestamp":1755807865000},"page":"110648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder"],"prefix":"10.1016","volume":"279","author":[{"given":"James J.","family":"Gattuso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5736-1241","authenticated-orcid":false,"given":"Bilgenur","family":"Bezcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0766-8911","authenticated-orcid":false,"given":"Da","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6270-6573","authenticated-orcid":false,"given":"Millicent N.","family":"Ekwudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2222-9714","authenticated-orcid":false,"given":"Carey","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8078-1390","authenticated-orcid":false,"given":"Carolina","family":"Gubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-8922","authenticated-orcid":false,"given":"Anthony J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-3971","authenticated-orcid":false,"given":"Thibault","family":"Renoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110648_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(09)60240-3","article-title":"Obsessive-compulsive disorder","volume":"374","author":"Abramowitz","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2025.110648_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuroscience.2015.11.009","article-title":"Using mice to model obsessive compulsive disorder: from genes to circuits","volume":"321","author":"Ahmari","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110648_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/nutrit\/nuz080","article-title":"Probiotics and prebiotics: focus on psychiatric disorders\u2013a systematic review","volume":"78","author":"Barbosa","year":"2020","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.neuropharm.2025.110648_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1192\/S0007125000297857","article-title":"Role of serotonin in obsessive-compulsive disorder","volume":"173","author":"Baumgarten","year":"1998","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110648_bib5","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1365-2982.2011.01796.x","article-title":"The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut\u2013brain communication","volume":"23","author":"Bercik","year":"2011","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2025.110648_bib6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ajmg.b.30897","article-title":"Sapap3 and pathological grooming in humans: results from the OCD collaborative genetics study","volume":"150","author":"Bienvenu","year":"2009","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatric Genetics."},{"key":"10.1016\/j.neuropharm.2025.110648_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110600","article-title":"Early stress-induced impaired microglial pruning of excitatory synapses on immature CRH-expressing neurons provokes aberrant adult stress responses","volume":"38","author":"Bolton","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2025.110648_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110648_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-9964(00)00139-0","article-title":"Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia","volume":"49","author":"Braff","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2025.110648_bib10","first-page":"1","article-title":"Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming","author":"Brownstien","year":"2024","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110648_bib11","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/npp.2015.44","article-title":"Environmental enrichment ameliorates behavioral impairments modeling schizophrenia in mice lacking metabotropic glutamate receptor 5","volume":"40","author":"Burrows","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110648_bib12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/schbul\/sbs117","article-title":"Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis","volume":"39","author":"Carhart-Harris","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2025.110648_bib13","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41592-022-01520-4","article-title":"Emu: species-level microbial community profiling of full-length 16S rRNA Oxford nanopore sequencing data","volume":"19","author":"Curry","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2025.110648_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.ne.15.030192.002033","article-title":"The role of the amygdala in fear and anxiety","volume":"15","author":"Davis","year":"1992","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110648_bib15","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41598-022-05480-9","article-title":"Changes in the stool and oropharyngeal microbiome in obsessive-compulsive disorder","volume":"12","author":"Dom\u00e8nech","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110648_bib16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley","year":"2003","journal-title":"Qjm"},{"key":"10.1016\/j.neuropharm.2025.110648_bib17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41398-022-02103-9","article-title":"Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice","volume":"12","author":"Fadahunsi","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110648_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108525","article-title":"Novel mechanism by which extracellular vesicles derived from Lactobacillus murinus alleviates deoxynivalenol-induced intestinal barrier disruption","volume":"185","author":"Fan","year":"2024","journal-title":"Environ. Int."},{"key":"10.1016\/j.neuropharm.2025.110648_bib19","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r13085","article-title":"Women are at greater risk of OCD than men: a meta-analytic review of OCD prevalence worldwide","volume":"81","author":"Fawcett","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110648_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1139118","article-title":"Excessive self-grooming, gene dysregulation and imbalance between the striosome and matrix compartments in the striatum of Shank3 mutant mice","volume":"16","author":"Ferhat","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110648_bib21","doi-asserted-by":"crossref","first-page":"G877","DOI":"10.1152\/ajpgi.00435.2001","article-title":"5-HT2A receptors: location and functional analysis in intestines of wild-type and 5-HT2A knockout mice","volume":"282","author":"Fiorica-Howells","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.neuropharm.2025.110648_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","article-title":"Gut\u2013brain axis: how the microbiome influences anxiety and depression","volume":"36","author":"Foster","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110648_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2024.01.001","article-title":"Effect of a single psilocybin treatment on fos protein expression in male rat brain","volume":"539","author":"Funk","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110648_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109689","article-title":"Acute administration of the NMDA receptor antagonists ketamine and MK-801 reveals dysregulation of glutamatergic signalling and sensorimotor gating in the Sapap3 knockout mouse model of compulsive-like behaviour","volume":"239","author":"Gattuso","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110648_bib25","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/jnc.16017","article-title":"Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: a systematic review","volume":"168","author":"Gattuso","year":"2024","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110648_bib26","article-title":"Psilocybin reduces grooming in the SAPAP3 knockout mouse model of compulsive behaviour","author":"Gattuso","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110648_bib85","doi-asserted-by":"crossref","first-page":"177304","DOI":"10.1016\/j.ejphar.2025.177304","article-title":"Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybin","volume":"991","author":"Gattuso","year":"2025","journal-title":"Euro. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110648_bib28","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/jn\/125.6.1401","article-title":"Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics","volume":"125","author":"Gibson","year":"1995","journal-title":"J. Nutr."},{"key":"10.1016\/j.neuropharm.2025.110648_bib29","first-page":"257","article-title":"Obsessive-compulsive disorder","volume":"37","author":"Goodman","year":"2014","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.neuropharm.2025.110648_bib30","article-title":"Convergent pathways of the gut microbiota\u2013brain axis and neurodegenerative disorders","volume":"10","author":"Gubert","year":"2022","journal-title":"Gastroenterol Rep (Oxf)."},{"key":"10.1016\/j.neuropharm.2025.110648_bib31","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/npp.2009.29","article-title":"5-HT2A and 5-HT2C receptors exert opposing effects on locomotor activity in mice","volume":"34","author":"Halberstadt","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110648_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109686","article-title":"Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor","volume":"27","author":"Harari","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.neuropharm.2025.110648_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40168-022-01227-w","article-title":"Lactobacillus murinus alleviate intestinal ischemia\/reperfusion injury through promoting the release of interleukin-10 from M2 macrophages via toll-like receptor 2 signaling","volume":"10","author":"Hu","year":"2022","journal-title":"Microbiome"},{"key":"10.1016\/j.neuropharm.2025.110648_bib34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature13908","article-title":"The contribution of de novo coding mutations to autism spectrum disorder","volume":"515","author":"Iossifov","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110648_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2018.05.012","article-title":"The abuse potential of medical psilocybin according to the 8 factors of the controlled substances act","volume":"142","author":"Johnson","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110648_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176014","article-title":"Implication of microbiota gut-brain axis in the manifestation of obsessive-compulsive disorder: preclinical and clinical evidence","author":"Kamble","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110648_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchp.2022.100349","article-title":"Seeking the psilocybiome: psychedelics meet the microbiota-gut-brain axis","volume":"23","author":"Kelly","year":"2023","journal-title":"Int. J. Clin. Health Psychol."},{"key":"10.1016\/j.neuropharm.2025.110648_bib38","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1038\/s41380-023-02280-z","article-title":"Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats","volume":"28","author":"Kiilerich","year":"2023","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110648_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.psycr.2024.100243","article-title":"The many faces of psilocybin-related psychosis: a case series","volume":"4","author":"Kim","year":"2025","journal-title":"Psychiatry Research Case Reports"},{"key":"10.1016\/j.neuropharm.2025.110648_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ebiom.2016.05.037","article-title":"Serotonin activates bacterial quorum sensing and enhances the virulence of Pseudomonas aeruginosa in the host","volume":"9","author":"Knecht","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neuropharm.2025.110648_bib41","series-title":"Schizophrenia: Methods and Protocols","first-page":"77","article-title":"Gastrointestinal and microbiome profiling in rodent models of neurological and psychiatric disorders","author":"Kong","year":"2023"},{"key":"10.1016\/j.neuropharm.2025.110648_bib42","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/02698811221084063","article-title":"Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms","volume":"36","author":"Kopra","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110648_bib43","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110648_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chom.2020.05.004","article-title":"The serotonin neurotransmitter modulates virulence of enteric pathogens","volume":"28","author":"Kumar","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.neuropharm.2025.110648_bib45","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/0269881119857204","article-title":"Microdosing psychedelics: more questions than answers? An overview and suggestions for future research","volume":"33","author":"Kuypers","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110648_bib46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41398-023-02323-7","article-title":"The Sapap3\u2212\/\u2212 mouse reconsidered as a comorbid model expressing a spectrum of pathological repetitive behaviours","volume":"13","author":"Lamothe","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110648_bib47","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbi.2024.04.017","article-title":"Mimicking bacterial infection in male mice changes sperm small RNA profiles and multigenerationally alters offspring behavior and physiology","volume":"119","author":"Liao","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2025.110648_bib48","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1271\/bbb.90095","article-title":"Effects of Psilocybe argentipes on marble-burying behavior in mice","volume":"73","author":"Matsushima","year":"2009","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.neuropharm.2025.110648_bib49","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110648_bib50","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.comppsych.2005.04.002","article-title":"Quality of life in obsessive-compulsive disorder before and after treatment","volume":"46","author":"Moritz","year":"2005","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110648_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113093","article-title":"Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice","volume":"401","author":"Odland","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110648_bib52","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3389\/fimmu.2020.00906","article-title":"The genus alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health","volume":"11","author":"Parker","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2025.110648_bib53","first-page":"375","article-title":"Pharmacological treatment of obsessive-compulsive disorder","volume":"37","author":"Pittenger","year":"2014","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.neuropharm.2025.110648_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211023","article-title":"A systematic study of microdosing psychedelics","volume":"14","author":"Polito","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110648_bib55","first-page":"2024","article-title":"Do the therapeutic effects of psilocybin involve actions in the gut?","author":"Reed","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110648_bib56","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1096\/fj.14-259598","article-title":"Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells","volume":"29","author":"Reigstad","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2025.110648_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fphar.2013.00045","article-title":"Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved","volume":"4","author":"Renoir","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110648_bib58","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110648_bib59","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/s41588-022-01245-2","article-title":"Exploring the genetic overlap between twelve psychiatric disorders","volume":"54","author":"Romero","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2025.110648_bib60","article-title":"What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review","volume":"6","author":"Santos","year":"2021","journal-title":"Porto Biomed J."},{"key":"10.1016\/j.neuropharm.2025.110648_bib61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41398-018-0327-z","article-title":"Cognitive impairment and autistic-like behaviour in SAPAP4-deficient mice","volume":"9","author":"Schob","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110648_bib62","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuron.2018.11.018","article-title":"Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder","volume":"101","author":"Sgritta","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110648_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214148","article-title":"Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head Twitch response induced by 5-hydroxytryptophan and psilocybin: translational implications","volume":"23","author":"Shahar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110648_bib64","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/bioinformatics\/bty1054","article-title":"DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays","volume":"35","author":"Singh","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neuropharm.2025.110648_bib65","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41398-023-02456-9","article-title":"Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder","volume":"13","author":"Singh","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110648_bib66","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00001574-200103000-00001","article-title":"Effects of serotonin on intestinal secretion and motility","volume":"17","author":"Spiller","year":"2001","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2025.110648_bib67","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/mp.2012.85","article-title":"Genome-wide association study of obsessive-compulsive disorder","volume":"18","author":"Stewart","year":"2013","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110648_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2019.08.004","article-title":"Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder","volume":"118","author":"Turna","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2025.110648_bib69","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/acps.13175","article-title":"The gut microbiome and inflammation in obsessive\u2010compulsive disorder patients compared to age\u2010and sex\u2010matched controls: a pilot study","volume":"142","author":"Turna","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neuropharm.2025.110648_bib70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/03007995.2022.2124071","article-title":"Is faecal microbiota transplantation a useful therapeutic intervention for psychiatric disorders? A narrative review of clinical and preclinical evidence","volume":"39","author":"Vasiliu","year":"2023","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.neuropharm.2025.110648_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g2183","article-title":"Obsessive-compulsive disorder","volume":"348","author":"Veale","year":"2014","journal-title":"Bmj"},{"key":"10.1016\/j.neuropharm.2025.110648_bib72","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2025.110648_bib73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.conb.2020.11.006","article-title":"Dissecting neural mechanisms of prosocial behaviors","volume":"68","author":"Walsh","year":"2021","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110648_bib74","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature11553","article-title":"Genomic approaches to studying the human microbiota","volume":"489","author":"Weinstock","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110648_bib75","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature06104","article-title":"Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice","volume":"448","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110648_bib76","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature24628","article-title":"Salt-responsive gut commensal modulates TH17 axis and disease","volume":"551","author":"Wilck","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110648_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107998","article-title":"Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction","volume":"168","author":"Wilson","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110648_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106223","article-title":"Mechanisms of pathogenesis and environmental moderators in preclinical models of compulsive-like behaviours","author":"Wilson","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2025.110648_bib79","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jad.2024.07.143","article-title":"Experience-dependent grooming microstructure alterations and gastrointestinal dysfunction in the SAPAP3 knockout mouse model of compulsive behaviour","volume":"363","author":"Wilson","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2025.110648_bib80","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110648_bib81","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12888-023-04963-x","article-title":"Effect of prebiotics, probiotics, synbiotics on depression: results from a meta-analysis","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110648_bib82","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1002\/imt2.88","article-title":"An overview of host\u2010derived molecules that interact with gut microbiota","volume":"2","author":"Zhang","year":"2023","journal-title":"Imeta"},{"key":"10.1016\/j.neuropharm.2025.110648_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105129","article-title":"A review of the neural basis underlying the acoustic startle response with a focus on recent developments in mammals","volume":"148","author":"Zheng","year":"2023","journal-title":"Neurosci. Biobehav. Rev."}],"updated-by":[{"DOI":"10.1016\/j.neuropharm.2025.110679","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:13:49Z","timestamp":1780028029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":83,"alternative-id":["S0028390825003569"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110648","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110648"}}